Rs12980275

23andMe blog

rs8099917(C) less likely to respond to Hepatitis C treatment.

rs12979860(C;C) better able to become naturally Hepatitis C virus-free. rs12980275(A) usually corresponds to the rs12979860(C)

Variants in IL28B in liver recipients and donors correlate with response to peg-interferon and ribavirin therapy for recurrent hepatitis C.

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b.

Peginterferon and ribavirin treatment for hepatitis C virus infection.

IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.

IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C.

Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.